Trump Downplays Pandemic At Prescott Rally

Oct 20, 2020
Associated Press | Alex Brandon


President Donald Trump held a rally at the Prescott Regional Airport on Monday, drawing enthusiastic supporters along with Arizona Governor Doug Ducey. It marked the president’s first appearance in the state since his recovery from COVID-19. 

The president — who chose not to wear a mask — told those in attendance that the pandemic was winding down. But in Arizona, health officials are counting hundreds of new COVID-19 cases each day. 

Johns Hopkins Center for American Indian Health

The pharmaceutical company Pfizer is recruiting tens of thousands of volunteers to test a possible new vaccine for the coronavirus disease. Some will be from the Navajo Nation. A legacy of systematic racism and unethical research has left many Navajos wary of participating in clinical trials. But health experts say it’s critical for Indigenous people to be involved for an equitable and scientifically sound process. KNAU’s Melissa Sevigny spoke about this dilemma with Laura Hammitt, of Johns Hopkins’ Center for American Indian Health, who is overseeing the trial on Navajo.

University of Arizona

A new study published yesterday by scientists at the University of Arizona shows antibodies to the coronavirus disease last for at least five months after infection. KNAU’s Melissa Sevigny reports.

Courtesty of ASU PPE Response Network

Students at Arizona State University have created a network of three hundred 3D printers, to meet ongoing demands for personal protective equipment or PPE. The project’s organizers say since the pandemic began they’ve filled more than fifteen thousand orders for gowns, masks, and other equipment needed by healthcare workers. KNAU’s Melissa Sevigny spoke about the project with Mark Naufel, the director of ASU’s Luminosity Lab, which brings students together from different departments to solve real-world problems.

Kris Hanning

Scientists at the University of Arizona say the virus that causes COVID-19 may have a surprising ability to relieve pain. Laboratory experiments with rodents show when the virus enters the body by binding to a gateway protein called neuropilin, it blocks the first step in the pathway that causes pain. That might explain why so many people diagnosed with COVID-19 don’t feel any symptoms. KNAU’s Melissa Sevigny spoke with Dr. Rajesh Khanna about his findings, published last week in the journal PAIN.